The PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) scanning are two leading technologies in the market of nuclear imaging equipment market for cancer and neurological imaging. Nuclear imaging is an emerging imaging method that employs a little amount of radioactive material associated with bodily cell components or chemicals attaching to tumor cells. Radioactive compounds may be found in the body using particular detecting devices to identify when and where they concentrate, and this technology has the ability to improve the prevention of disease, clinical research, medical diagnosis, and therapy.
PET creates digital pictures of the tissue chemicals, such as the metabolism of sugar. Usually, the patient receives a sugar injection with radioactively tagged sugar; if it is present and is traced with the aid of a scanner, it accumulates radioactive sugar on the tumor in the body. However, a small quantity of radioactive material is injected into the patient's vein in SPECT, and it may be traced by using a scanner to monitor tissue blood flow and chemical body responses. The reasons leading to PET and SPECT market include raising awareness of the benefits of nuclear imaging among doctors and clinical scientists, along with expanding applications such as cancer and neurology illnesses. In addition, the growing geriatric population and expanding horizons of SPECT and PET imagery applications are boosting the nuclear imaging equipment market due to continual discovery and new radiopharmaceuticals... Read more